Equity
€405,245 ▲ 110%
Equity rose in 2025 from €192,873 to €405,245.
SCANRE
Overview
Lifetime
2 annual accounts with figures on one time axispeak €281,557 (2025)
€281,557▲ 11.0%
peak €212,372 (2025)
€212,372▲ 11.8%
peak €405,245 (2025)
€405,245▲ 110%
€130,889▲ 93.1%
Board1 name since 2024
1 director
Documentsfilings and deeds
05-06-202656 days before the deadline
2025micro format
Equity from €192,873 to €405,245Debts from €67,779 to €130,889Cash from €125,156 to €419,466
Key points
from the 2025 annual accountsTurnover
≈ €430,000 estimated
The micro format states no turnover.
Position in the sector
€212,372
Higher net result than 89% of companies in human health. Sector median €59,542 · 21,298 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 3,127 companies had the same profile as SCANRE has now. Each dot stands for 8 companies, two years later.
97.2%
were still trading
1.9%
stopped another way
0.8%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,127 companies, not a prediction for SCANRE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1012441062
Incorporation
Founding capital of €3,000, 100 shares · Founder: · Appointment: (director) · published on 16-08-2024 · Gazette deed
First establishment
Gierledreef 32, Turnhout
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| SCANRE Turnhout | €536,134 | €281,557 | 75.6% | - |
| Dr Adeline Higuet Uccle | €605,328 | €288,320 | 31.2% | - |
| OOGCENTRUM EOS Mol | €662,396 | €291,676 | 10.7% | - |
| Dokter Vinke Geel | €567,057 | €252,013 | 59.9% | - |
| o.lives Edegem | €541,460 | €246,318 | 75.7% | - |
| OculoMax Bonheiden | €466,509 | €281,811 | 84.3% | - |
| Dr. Noémie Ampe Antwerp | €563,804 | €260,406 | 80.0% | - |
These companies have the same main activity as SCANRE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €467,000 and €662,000, founded between 2023 and 2024.
Official details
Source: KBO- Status
- Active since 13-08-2024Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.362.693.8312300 Turnhout, since 13-08-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 20-03-2026
Annual accounts 2025
- €281,557▲ 11.0%
- €212,372▲ 11.8%
- €405,245▲ 110%
- €536,134▲ 106%
- Filing
- Filed on 05-06-2026, 56 days before the end of the filing period
Insights on SCANRE
SCANRE has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €405,245 and a net result of €212,372.
Its solvency ranks better than 64% of 21,311 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 05-06-2026, 56 days before the deadline€281,557
▲ 11.0%
€275,828
▲ 8.9%
€212,372
▲ 11.8%
€405,245
▲ 110%
75.6%
▲ 1.6 percentage points
4.10
▲ 0.25
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €430,000. Estimated: probably between €380,000 and €590,000.
Balance sheet
balance sheet total €536,134 on 31-12-2025What the company ownsHow it is paid for
in euro
in euro
Position in the sector
75.6%
Higher than 64% of 21,311 companies in 2025.
4.10
Higher than 63% of 20,862 companies in 2025.
39.6%
Higher than 75% of 21,162 companies in 2025.
SCANRE
Middle half of the sector
80% of the sector
Micro accounts in human health (NACE 86)
Net result: top quarter · Equity: top quarter · Balance sheet total: middle half · Working capital: top quarter
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| Balance sheet: assets | |||
20/58 |
536,134 | 260,651 | |
29/58 |
536,134 | 260,651 | |
40/41 |
33,191 | 46,829 | |
41 |
33,191 | 46,829 | |
54/58 |
419,466 | 125,156 | |
490/1 |
83,477 | 88,666 | |
| Balance sheet: equity and liabilities | |||
10/49 |
536,134 | 260,651 | |
10/15 |
405,245 | 192,873 | |
10/11 |
3,000 | 3,000 | |
13 |
402,245 | 189,873 | |
133 |
402,245 | 189,873 | |
17/49 |
130,889 | 67,779 | |
42/48 |
130,889 | 67,779 | |
44 |
0 | 3,856 | |
440/4 |
0 | 3,856 | |
45 |
130,889 | 63,923 | |
450/3 |
130,889 | 63,923 | |
| Income statement | |||
9900 |
281,557 | 253,697 | |
62 |
5,474 | - | |
640/8 |
255 | 465 | |
9901 |
275,828 | 253,231 | |
75/76B |
2,483 | 602 | |
75 |
2,483 | 602 | |
65/66B |
158 | 38 | |
65 |
158 | 38 | |
9903 |
278,153 | 253,796 | |
67/77 |
65,781 | 63,923 | |
9904 |
212,372 | 189,873 | |
9905 |
212,372 | 189,873 | |
| Appropriation of the result | |||
9906 |
212,372 | 189,873 | |
691/2 |
212,372 | 189,873 | |
6921 |
212,372 | 189,873 | |
| Document | |||
The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 05-06-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankKey figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 |
|---|---|---|---|
| 0 | - | ||
| 294,309 | - | ||
| 405,245 | 192,873 | ||
| 75.6% | 74.0% | ||
| 4.10 | 3.85 | ||
| 0.32 | 0.35 | ||
| 52.4% | 98.4% | ||
| 39.6% | 72.8% |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 |
|---|---|---|
| Financial fixed assets | €0 | - |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
Insights on SCANRE
The operating result for 2025 is 9% higher than in 2024.
Debt's share of the balance-sheet total falls from 26.0% to 24.4%. Equity and debt are higher.
Board & ownership
Board
1 director, since incorporationDirector (not named in the articles)
since 12-08-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 05-06-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Indien de vennootschap door meer dan één bestuurders wordt bestuurd, mag iedere bestuurder, alleen optredend, alle handelingen stellen die…”deed of 16-08-2024
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
Board
Mandates as a list
-
- Director (not named in the articles), from 12-08-2024 to date
Control
Founder
This company
SCANRE
Equity €405,245
Profit €212,372 in 2025
Capital
- Contribution
- €3,000
- Shares
- 100
- Contribution per share
- €30
- Equity per share
- €4,052 in 2025
- Source
- deed of 16-08-2024
Articles of association
deed of 16-08-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
- 100 shares
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Wednesday of June at 16:00
Shareholders
At incorporation
deed of 16-08-2024 ↗
- 100 shares (100%) · €3,000 in cash
Network & group
No group
SCANRE has no parent and no holdings in its annual accounts. is the only director. SCANRE shares no director with another company.
Timeline
Timeline
6 events since 2024Filings
Financial
Establishments
202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 56 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:1012441062
2025
Equity above €200,000 equity €405,245 ▲110% With a profit in every financial year since 2024, equity grows to €405,245.
Annual accounts 2024 filed NBBmicro format · 9 days before the deadline
2024
IncorporationFounding capital of €3,000, 100 shares · Founder: · Appointment: (director) · published on 16-08-20244 points ▸
- Founder,
- Founding capital, €3,000, 100 shares
- Registered office clause, Gierledreef 32, 2300 Turnhout
- Director appointment, (director (not named in the articles))
- The deed holds 4 more points.
First establishment Gierledreef 32, Turnhout
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Identity
- Enterprise number
- 1012.441.062
- VAT number
- BE 1012.441.062
- Peppol ID
- 0208:1012441062
- Other Peppol ID
- 9925:BE1012441062
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 13-08-2024
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Wednesday of June at 16:00deed of 16-08-2024 (in Dutch)
- Peppol
- Reachable since 20-03-2026Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- SCANRE in Dutch
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 16-08-2024 (in Dutch)
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Gierledreef 32, 2300 Turnhout”deed of 16-08-2024 (in Dutch)
Activities
NACEBEL 202586220
Specialist medical practice main activity
Codes under NACEBEL 2008
86220
Human health activities main activity
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “De uitoefening van de anesthesie en de intensieve geneeskunde door de geneesheren-aandeelhouders in naam en voor rekening van de…”deed of 16-08-2024 (in Dutch)
10 activities
- De uitoefening van de anesthesie en de intensieve geneeskunde door de geneesheren-aandeelhouders in naam en voor rekening van de vennootschap
- De geneeskundige activiteit wordt uitgeoefend onder de persoonlijke aansprakelijkheid van de arts en de bijkomende aansprakelijkheid van de vennootschap
- De arts-aandeelhouder brengt zijn volledige medische activiteit in,in de vennootschap
- De activiteit omvat impliciet de inning der erelonen door en voor de vennootschap en de betaling aan de artsen-aandeelhouders van een vergoeding in verhouding tot de prestaties die zij voor rekening van de vennootschap geleverd hebben
- De vennootschap mag zich associëren met een of meerdere artsen van dezelfde of aanverwante disciplines of met een of meerdere burgerlijke doktersvennootschappen,met het oog op een gezamenlijke uitoefening van haar activiteiten
- De vennootschap oefent haar activiteit uit mits de naleving van de regelen van de medische deontologie
- Het ter beschikking stellen van alle nodige middelen aan artsen die tot de vennootschap toegetreden zijn;het inrichten van de praktijk voor de geneeskunde,de uitvoering van de technisch,medische,radiografische en laboratoriumprestaties in verband met voormelde discipline
- Het inrichten van algemene diensten en een medisch secretariaat in het bijzonder,die nuttig of nodig zijn voor de uitoefening van voornoemde activiteiten
- De aankoop,het huren en invoeren van alle medische apparatuur en begeleidende accommodaties voor voornoemde activiteiten
- De mogelijkheid scheppen om de arts-aandeelhouder toe te laten zich verder te bekwamen ten einde in zijn discipline aan de spits van de evolutie te blijven,bijvoorbeeld via het ontwikkelen en uitgeven van educatief materiaal,onderzoeken van nieuwe technieken,toestellen en materialen,deelname aan binnen- en buitenlandse congressen en seminaries alsook het zelf organiseren van binnen- en buitenlandse congressen en seminaries
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Gierledreef 32 registered office 2300 Turnhout | 13-08-2024 | 2.362.693.831 |
Buildings and parcels at the address
- Ground area
- 1,247 m²
- Buildings
- 220 m²
- Volume, LiDAR
- 1,335 m³
- Tallest building
- 12.2 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 13453O0126/00E009 | 1,247 m² | 1 · 220 m² | 12.2 m · 2 |